Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Kissling, W.
1994.
Schizophrenie und Lebensqualität.
Vol. 5,
Issue. ,
p.
81.
Dauwalder, J. P.
and
Ciompi, L.
1995.
Cost-effectiveness over 10 years.
Social Psychiatry and Psychiatric Epidemiology,
Vol. 30,
Issue. 4,
p.
171.
Sclar, D A
Robison, L M
Skaer, T L
Galin, R S
Legg, R F
Nemec, N L
Hughes, T E
Buesching, D P
and
Morgan, M
1995.
Antidepressant Pharmacotherapy: Economic Evaluation of Fluoxetine, Paroxetine and Sertraline in a Health Maintenance Organization.
Journal of International Medical Research,
Vol. 23,
Issue. 6,
p.
395.
Bellantuono, Cesario
and
Balestrieri, Matteo
1995.
La valutazione dei costi del trattamento farmacologico nella depressione. Una revisione critica della letteratura.
Epidemiologia e Psichiatria Sociale,
Vol. 4,
Issue. 1,
p.
51.
Williams, Richard
and
Dickson, Ruth A
1995.
Economics of Schizophrenia.
The Canadian Journal of Psychiatry,
Vol. 40,
Issue. 7_suppl,
p.
60.
Aitchison, Katherine J.
and
Kerwin, Robert W
1997.
Cost-effectiveness of clozapine.
British Journal of Psychiatry,
Vol. 171,
Issue. 2,
p.
125.
Burke, Michael J.
1997.
CLINICOECONOMICS IN GEROPSYCHIATRY.
Psychiatric Clinics of North America,
Vol. 20,
Issue. 1,
p.
219.
Lin, E.
Goering, P. N.
Lesage, A.
and
Streiner, D. L.
1997.
Epidemiologic assessment of overmet need in mental health care.
Social Psychiatry and Psychiatric Epidemiology,
Vol. 32,
Issue. 6,
p.
355.
eLetters
No eLetters have been published for this article.